menu search

Merck's keytruda shows positive results in confirmatory trial as treatment for rare form of esophageal cancer

Merck & Co. MRK, -1.53% said Friday a late-stage trial of its blockbuster cancer drug Keytruda plus trastuzumab, fluoropyrimidine- and platinum-contai...

October 20, 2023, 8:13 am

Enphase energy: avoid ahead of anticipated weak results and outlook

After the close of Wednesday's regular session, Enphase Energy's main competitor SolarEdge Technologies...

October 19, 2023, 11:22 pm

Tourmaline bio announces closing of merger with talaris therapeutics and concurrent private placement of $75 million

Tourmaline will be focused on advancing TOUR006, its differentiated anti-IL-6 antibody, to treat thyroid eye disease (TED), atherosclerotic cardiovasc...

October 19, 2023, 9:37 pm

Allyx therapeutics to present phase 1 data for lead compound alx-001 at the 16th clinical trials on alzheimer’s disease meeting

Allyx’s lead compound, ALX-001, is a small molecule with unique mechanism of action at mGluR5, to protect and preserve synapses in neurodegenerative...

October 19, 2023, 8:05 pm

Ipo update: chromocell therapeutics seeks $8.7 million in micro-ipo

Chromocell Therapeutics Corporation has filed for an $8.7 million IPO to develop its treatment for chronic pain conditions. The company's lead compoun...

October 19, 2023, 5:31 pm

Intellia's (ntla) ind for gene-editing therapy gets fda clearance

Intellia (NTLA) gets FDA nod to begin a phase III study on its gene editing candidate, NTLA-2001 to tre...

October 19, 2023, 12:47 pm

Carlyle commodities reveals phase 2 drilling strategy at newton project in british columbia

Carlyle Commodities Corp (CSE:CCC, OTCQB:CCCFF) has outlined the phase 2 drilling strategy at its 100% ...

October 19, 2023, 9:04 am

Maia biotechnology to present preliminary safety and efficacy data from thio-101 phase 2 clinical trial at european society for medical oncology congress 2023

CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology to Present Preliminary Safety and Efficacy Data from THIO-101 pha...

October 19, 2023, 8:35 am

Treasury yields surge, country garden wobbles, global markets on guard

Financial markets are once again immersed in a phase of risk aversion, a sentiment spurred by the notab...

October 19, 2023, 5:23 am

Gold price forecast: xau/usd’s further upside hinges on fed’s jerome powell

Gold price has entered a phase of bullish consolidation near $1,950, having reached an over two-month h...

October 19, 2023, 3:59 am

Calliditas therapeutics to present seven abstracts at the american society of nephrology (asn) kidney week 2023

STOCKHOLM , Oct. 19, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas"), today announced seven ab...

October 19, 2023, 3:58 am

Sage therapeutics: several neuropsychiatric disorder data readouts in 2024

Sage Therapeutics, Inc. received FDA approval along with Biogen for its drug ZURZUVAE for the treatment of postpartum depression, with a planned launc...

October 18, 2023, 6:52 pm

Netflix boosts prices on some plans in us, uk & france

Netflix said today it's raising prices on some of its plans in the U.S., U.K and France with the Premium subscription Stateside now set at $22.99 a mo...

October 18, 2023, 4:32 pm

Hookipa pharma announces publication of preclinical data of hepatitis b virus (hbv) therapeutic vaccine developed in collaboration with gilead sciences

HB-400, a novel arenaviral therapeutic vaccine, generates robust T cell responses specific to hepatitis B virus with high antibody levels in a preclin...

October 18, 2023, 11:01 am

Why is viking therapeutics (vktx) stock moving today?

Viking Therapeutics (NASDAQ: VKTX ) stock is on the move Wednesday as the clinical-stage biopharmaceutical company reveals data from a clinical trial....

October 18, 2023, 10:01 am

Sage therapeutics jump 5% on huntington's drug call by fda

Shares of Sage Therapeutics Inc jumped 5% in premarket trading following the announcement that the US Food and Drug Administration (FDA) has granted...

October 18, 2023, 7:41 am

Viking therapeutics joins weight loss drug bandwagon as trial data impresses

Viking Therapeutics (NASDAQ:VKTX) shares shot up 12% in overnight US trading as the drug developer revealed more impressive trial data from a treatmen...

October 18, 2023, 7:06 am

Bitcoin price is about to see “liftoff” if it’s able to hold one crucial level

Bitcoin price is consolidating above the $28,000 support. BTC could gain bullish momentum if it clears the $28,550 resistance zone. Bitcoin started a ...

October 18, 2023, 3:31 am

Scancell to speak at prestigious vaccine event

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), which is developing immunotherapies for cancer and infectious disease, said its chief executive and chie...

October 18, 2023, 3:14 am

Cingulate to host cns key opinion leader panel in new york city

Expert Analysis of Cingulate, its phase 3 ADHD Adult Data, Anxiety, and PTR™ Drug Delivery Platform I...

October 17, 2023, 6:22 pm


Search within

Pages Search Results: